Waters Co. (NYSE:WAT) SVP Elizabeth B. Rae sold 29,326 shares of the firm’s stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $213.12, for a total value of $6,249,957.12. Following the sale, the senior vice president now owns 23,932 shares of the company’s stock, valued at approximately $5,100,387.84. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Shares of WAT traded down $0.90 during mid-day trading on Friday, hitting $211.08. The stock had a trading volume of 3,941 shares, compared to its average volume of 565,040. The company has a market cap of $13.76 billion, a PE ratio of 25.48, a PEG ratio of 2.54 and a beta of 1.04. The company’s fifty day simple moving average is $218.46 and its two-hundred day simple moving average is $214.21. The company has a quick ratio of 1.63, a current ratio of 2.25 and a debt-to-equity ratio of 11.40. Waters Co. has a fifty-two week low of $173.41 and a fifty-two week high of $255.21.

Waters (NYSE:WAT) last issued its earnings results on Tuesday, October 29th. The medical instruments supplier reported $2.13 EPS for the quarter, hitting the consensus estimate of $2.13. The company had revenue of $577.28 million during the quarter, compared to analyst estimates of $588.35 million. Waters had a return on equity of 77.73% and a net margin of 23.98%. The business’s revenue was down .1% on a year-over-year basis. During the same quarter last year, the firm earned $1.92 EPS. Equities analysts expect that Waters Co. will post 8.84 earnings per share for the current year.

A number of equities research analysts have weighed in on WAT shares. ValuEngine lowered Waters from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Bank of America lowered Waters from a “neutral” rating to an “underperform” rating in a research note on Tuesday, July 16th. Needham & Company LLC restated a “hold” rating on shares of Waters in a research note on Tuesday, October 29th. TheStreet lowered Waters from a “b” rating to a “c+” rating in a research note on Tuesday, October 29th. Finally, Robert W. Baird raised their price objective on Waters from $208.00 to $217.00 and gave the company a “neutral” rating in a research note on Wednesday, October 30th. Six equities research analysts have rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $209.60.

Several institutional investors and hedge funds have recently modified their holdings of WAT. Compagnie Lombard Odier SCmA acquired a new position in shares of Waters in the 2nd quarter worth approximately $37,000. CSat Investment Advisory L.P. grew its position in shares of Waters by 212.5% in the 2nd quarter. CSat Investment Advisory L.P. now owns 225 shares of the medical instruments supplier’s stock worth $48,000 after acquiring an additional 153 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in shares of Waters in the 3rd quarter worth approximately $51,000. Private Capital Group LLC grew its position in shares of Waters by 92.0% in the 2nd quarter. Private Capital Group LLC now owns 288 shares of the medical instruments supplier’s stock worth $56,000 after acquiring an additional 138 shares in the last quarter. Finally, Amica Retiree Medical Trust bought a new stake in shares of Waters in the 2nd quarter worth approximately $69,000. Institutional investors own 95.15% of the company’s stock.

About Waters

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Further Reading: What is required to own or exchange cryptocurrency?

Insider Buying and Selling by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.